The Pharmacy Benefit Management community showcases the latest news and innovative trends employers use when choosing a pharmacy benefit management partner. The community also analyses the latest tools and technology PBMs use to help streamline employer health care costs through processing prescription drug claims, direct-mail delivery etc.
Pharmacy benefit plan design continues to shift, becoming more advanced and putting more choice in the hands of the member.
A recent study produced by Vistane for the Pharmaceutical Care Management Association (PCMA) has found that through greater use of preferred and limited pharmacy networks payers, including Medicare, Medicaid, and employers, could save a combined $115 billion of the next decade.
Greater use of "preferred" and "limited" pharmacy networks could save taxpayers $115 billion over the next 10 years on prescription costs, according to a new study.
The Pharmaceutical Care Management Association (PCMA) says a study it commissioned shows that an expanded use of preferred and limited pharmacy networks could save payers $115 billion over the next 10 years.
CVS Caremark focus on medication adherence saved PBM clients more than $643 million in 2012
Pharmacy benefit management helps individuals with access to drugs and pharmacies
Humana Pharmacy Solutions (HPS), the pharmacy benefits management division of Humana Inc. (NYSE: HUM), topped the Flaspohler Research Group’s study of fellow pharmacy benefit managers in three categories: Effective Technology, Effective Cost-Management Tools, and Relationship Oriented.
Today - ATLANTA -- May 24, 2013 -- Now in its fourth year, The Institute for HealthCare...
05/20/2013 - Americans love to save money, especially in a tight economy. And everyone loves a good...
05/20/2013 -
In recent months, Pharmacy Benefit Managers (PBMs) have emerged as vocal critics of the drug industry's reliance on copay cards, coupons, and other tools to help patients offset the cost of innovative brand-name medicines.
A white paper from Elsevier
The President and some members of Congress have proposed requiring that prescription drug manufacturers pay rebates to the federal government for drugs dispensed to Medicaid/Medicare dual-eligible beneficiaries and other low-income seniors through the Medicare Part D program.